Bioceres Crop Solutions Corp. (BIOX) — Institutional Holders, Q2 2026
28 institutional investment managers reported a BIOX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.9M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
BIOX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MIRAE ASSET GLOBAL ETFS Ltd.Added · +332,638 sh+$116.5K
- UBS Group AGAdded · +50,115 sh+$17.5K
- GOLDMAN SACHS GROUPAdded · +12,570 sh+$4.4K
- Tower Research Capital (TRC)New · +9,547 sh+$3.3K
- GROUP ONE TRADING, L.P.Added · +3,379 sh+$1.2K
Biggest sellers
- MARSHALL WACE, LLPSold out · -702,478 sh-$245.9K
- STATE OF WISCONSIN INVESTMENT BOARDSold out · -188,800 sh-$66.1K
- Invesco Ltd.Sold out · -126,283 sh-$44.2K
- TWO SIGMA INVESTMENTSTrimmed · -65,286 sh-$22.9K
- STIFEL FINANCIALTrimmed · -53,500 sh-$18.7K
BIOX 13F holders ranked 1–28 of 28
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Solel Partners#1 · 4,579,364 sh | 4,579,364 | $1.6M | 0.27% | 0.0% |
| 2 | MIRAE ASSET GLOBAL ETFS Ltd.#2 · 1,406,223 sh | 1,406,223 | $492.3K | <0.01% | +31.0% |
| 3 | Long Focus Capital Management#3 · 829,748 sh | 829,748 | $290.5K | <0.01% | 0.0% |
| 4 | ARDSLEY ADVISORY PARTNERS#4 · 475,000 sh | 475,000 | $166.3K | 0.02% | 0.0% |
| 5 | UBS Group AG#5 · 408,276 sh | 408,276 | $142.9K | 0.00% | +14.0% |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#6 · 212,930 sh | 212,930 | $74.5K | 0.00% | -1.1% |
| 7 | PNC FINANCIAL SERVICES GROUP#7 · 133,000 sh | 133,000 | $46.5K | 0.00% | 0.0% |
| 8 | GOLDMAN SACHS GROUP#8 · 129,445 sh | 129,445 | $45.3K | 0.00% | +10.8% |
| 9 | PING CAPITAL MANAGEMENT#9 · 55,000 sh | 55,000 | $19.3K | — | 0.0% |
| 10 | JANE STREET GROUP#10 · 36,268 sh | 36,268 | $12.7K | 0.00% | +6.3% |
| 11 | TWO SIGMA INVESTMENTS#11 · 30,026 sh | 30,026 | $10.5K | 0.00% | -68.5% |
| 12 | STIFEL FINANCIAL#12 · 29,588 sh | 29,588 | $10.4K | 0.00% | -64.4% |
| 13 | GEODE CAPITAL MANAGEMENT#13 · 23,836 sh | 23,836 | $8.3K | 0.00% | -39.0% |
| 14 | One Degree Advisors#14 · 23,038 sh | 23,038 | $7.0K | <0.01% | 0.0% |
| 15 | MORGAN STANLEY#15 · 18,014 sh | 18,014 | $6.3K | 0.00% | -0.3% |
| 16 | GROUP ONE TRADING, L.P.#16 · 15,257 sh | 15,257 | $5.3K | 0.00% | +28.4% |
| 17 | Tower Research Capital (TRC)#17 · 9,547 sh | 9,547 | $3.3K | <0.01% | New |
| 18 | MJT & Associates Financial Advisory Group#18 · 1,487 sh | 1,487 | $521.00 | — | New |
| 19 | J.Safra Asset Management#19 · 1,400 sh | 1,400 | $490.00 | 0.00% | New |
| 20 | OSAIC#20 · 1,205 sh | 1,205 | $419.00 | 0.00% | 0.0% |
| 21 | SIMPLEX TRADING#21 · 775 sh | 775 | $271.00 | 0.00% | -98.3% |
| 22 | EFG International AG#22 · 750 sh | 750 | $263.00 | 0.00% | 0.0% |
| 23 | JONES FINANCIAL COMPANIES LLLP#23 · 651 sh | 651 | $217.00 | 0.00% | 0.0% |
| 24 | HARBOUR INVESTMENTS#24 · 352 sh | 352 | $123.00 | 0.00% | 0.0% |
| 25 | SBI Securities , Ltd.#25 · 279 sh | 279 | $98.00 | — | +0.7% |
| 26 | Allworth Financial#26 · 211 sh | 211 | $74.00 | 0.00% | 0.0% |
| 27 | JPMORGAN CHASE#27 · 29 sh | 29 | $10.00 | 0.00% | 0.0% |
| 28 | Caitong International Asset Management , Ltd#28 · 1 sh | 1 | $0.00 | 0.00% | 0.0% |
Funds that sold out of BIOX in Q2 2026 (7)
Held BIOX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| MARSHALL WACE, LLP702,478 sh | 702,478 | $309.1K |
| STATE OF WISCONSIN INVESTMENT BOARD188,800 sh | 188,800 | $84.0K |
| Invesco Ltd.126,283 sh | 126,283 | $56.2K |
| R Squared Ltd22,075 sh | 22,075 | $9.8K |
| XTX Topco Ltd17,615 sh | 17,615 | $7.8K |
| BNP PARIBAS FINANCIAL MARKETS3 sh | 3 | $1.00 |
| Hanson & Doremus Investment Management50 sh | 50 | $0.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.